Skip to main content
Premium Trial:

Request an Annual Quote

Warnex to Distribute Gendia's Tests in Canada

NEW YORK (GenomeWeb News) – Quebec-based bioanalytical company Warnex said today that it has agreed to become the exclusive distributor of molecular diagnostic tests for the Gendia network in Canada.
 
Gendia is an international lab testing network with over 50 labs in the US, Europe, and Australia, and it offers more than 2,000 different genetic tests. Its goal is to provide and improve access, cost effectiveness, and quality for diagnostic tests for rare genetic disorders.
 
Warnex CEO Mark Busgang said in a statement that the agreement will help “provide access to a vast portfolio of highly specialized genetic tests ... that are not readily available in Canada.”

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.